Back to mobile site

Scotiabank Reiterates Sector Outperform Rating on Tempest Therapeutics (TPST)

October 14, 2024 10:41 AM EDT Send to a Friend
Scotiabank analyst George Farmer reiterated a Sector Outperform rating and $13.00 price target on Tempest Therapeutics (NASDAQ: TPST).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login